These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24924285)

  • 21. A combination of intravitreal bevacizumab injection with tunable argon yellow laser photocoagulation as a treatment for adult-onset Coats' disease.
    Wang KY; Cheng CK
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):525-30. PubMed ID: 21951171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coats disease in a patient with Fanconi anemia: a case report.
    Martín-Sanz R; Peña D; López-Miguel A; Coco-Martín MB; González-García H; Álvarez-Guisasola FJ; Pastor JC
    Eur J Ophthalmol; 2015; 25(2):182-3. PubMed ID: 25264118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal bevacizumab for type 2 idiopathic macular telangiectasia.
    Veloso CE; Vianna RN; Pelayes DE; Nehemy MB
    Ophthalmic Res; 2013; 49(4):205-8. PubMed ID: 23364325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II.
    Kovach JL; Rosenfeld PJ
    Retina; 2009 Jan; 29(1):27-32. PubMed ID: 18936721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal bevacizumab for perifoveal telangiectasia.
    Jonas JB; Libondi T; von Baltz S; Beutelspacher S
    Acta Ophthalmol; 2011 Nov; 89(7):e607-8. PubMed ID: 20946328
    [No Abstract]   [Full Text] [Related]  

  • 26. Intravitreal bevacizumab for macular complications from retinal arterial macroaneurysms.
    Pichi F; Morara M; Torrazza C; Manzi G; Alkabes M; Balducci N; Vitale L; Lembo A; Ciardella AP; Nucci P
    Am J Ophthalmol; 2013 Feb; 155(2):287-294.e1. PubMed ID: 23111179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful use of anti-VEGF treatment for subretinal hemorrhage and fluid in a young patient with choroidal osteoma.
    Carle MV; Chu TG; Liao D; Boyer DS
    Ophthalmic Surg Lasers Imaging Retina; 2014; 45(2):169-71. PubMed ID: 24635160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of anti-vascular endothelial growth factor therapy in subretinal neovascularization secondary to macular telangiectasia type 2.
    Narayanan R; Chhablani J; Sinha M; Dave V; Tyagi M; Pappuru RR; Kuppermann BD
    Retina; 2012; 32(10):2001-5. PubMed ID: 22990322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of intravitreal bevacizumab in the treatment of Coats disease in children.
    Lin CJ; Hwang JF; Chen YT; Chen SN
    Retina; 2010 Apr; 30(4):617-22. PubMed ID: 19996822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spectral-Domain Optical Coherence Tomography of Subretinal Hyperreflective Exudation in Myopic Choroidal Neovascularization.
    Bruyère E; Caillaux V; Cohen SY; Martiano D; Ores R; Puche N; Souied EH
    Am J Ophthalmol; 2015 Oct; 160(4):749-58.e1. PubMed ID: 26164828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repeated intravitreal bevacizumab (Avastin(®)) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation.
    Schmidinger G; Maar N; Bolz M; Scholda C; Schmidt-Erfurth U
    Acta Ophthalmol; 2011 Feb; 89(1):76-81. PubMed ID: 21272288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dexamethasone implant for the treatment of edema related to idiopathic macular telangiectasia.
    Sandali O; Akesbi J; Rodallec T; Laroche L; Nordmann JP
    Can J Ophthalmol; 2013 Aug; 48(4):e78-80. PubMed ID: 23931489
    [No Abstract]   [Full Text] [Related]  

  • 33. Resolution of subretinal haemorrhage and fluid after intravitreal bevacizumab in aggressive peripapillary subretinal neovascularization.
    Soliman W; Lund-Andersen H; Larsen M
    Acta Ophthalmol Scand; 2006 Oct; 84(5):707-8. PubMed ID: 16965507
    [No Abstract]   [Full Text] [Related]  

  • 34. Significance of the hyperautofluorescent ring associated with choroidal neovascularisation in eyes undergoing anti-VEGF therapy for wet age-related macular degeneration.
    Camacho N; Barteselli G; Nezgoda JT; El-Emam S; Cheng L; Bartsch DU; Freeman WR
    Br J Ophthalmol; 2015 Sep; 99(9):1277-83. PubMed ID: 25777818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary Coats' response to retinal vasculitis managed with bevacizumab.
    Chaudhary P; Varshney A; Videkar C
    Indian J Ophthalmol; 2018 Sep; 66(9):1355-1357. PubMed ID: 30127171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spectral-domain optical coherence tomography of the macula in preterm infants treated with bevacizumab for retinopathy of prematurity.
    Dorta P; Kychenthal A
    Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):321-6. PubMed ID: 25856817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of IRVAN syndrome with observation.
    Basha M; Brown GC; Palombaro G; Shields CL; Shields JA
    Ophthalmic Surg Lasers Imaging Retina; 2014 May; 45 Online():e18-22. PubMed ID: 24766157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined intravitreal anti-vascular endothelial growth factor (Avastin) and photodynamic therapy to treat retinal juxtapapillary capillary haemangioma.
    Mennel S; Meyer CH; Callizo J
    Acta Ophthalmol; 2010 Aug; 88(5):610-3. PubMed ID: 19222401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unusual association of peripheral retinal ischemia-induced neovascular glaucoma and neurofibromatosis type 1.
    Elgi U; Berker N; Teke MY; Simsek T; Ozdal P
    J Pediatr Ophthalmol Strabismus; 2010 May; 47 Online():e1-3. PubMed ID: 21214163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
    Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
    J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.